We are industry leaders in Molecular Diagnostics.
Natural Molecular Testing sits at the four-way intersection of technology, molecular biology, genetics and modern medicine. We are helping to revolutionize the practice of medicine by leveraging cutting-edge research and technology and applying it to real-world challenges. We provide physicians with access to information on individual patients at the cellular level, and thus transform the concept of “personalized medicine” into a present day reality.
Natural Molecular was founded in Seattle, Washington, one of the world’s leading centers of biomedical technology and research. Our vision has always been to speed the advancement of “personalized medicine” and to bring its principles into actual practice. The thought-leadership and technical achievements of our own people, as well as our colleagues in the field, have allowed us to realize – and expand – this vision.
Contact us to learn about how our service can be a valuable resource for your clinic. Call 1-888-442-8881
Our Executive Team.
Beau Fessenden, CEO
Mr. Fessenden is a native of Seattle and has over fifteen years of experience with major technology organizations. After graduating from the University of Helsinki, he built two high throughput sequencing DNA laboratories for two well known biotechnology companies in the Puget Sound area. He started NMTC in 2008 and has overseen the company’s exponential growth as a leader in molecular testing. Mr. Fessenden lives in Normandy Park and enjoys spending time with his wife and two kids.
Karthikeshwar Kasirajan, M.D., Chief Medical Officer
Dr. Kasirajan is a vascular surgeon and received his undergraduate degree at Madras Medical College in Madras India. He then did his general surgery residency at Case Western Reserve and then completed his fellowship at the Cleveland Clinic. Dr. Kasirajan has held several academic appointments including being an Associate Professor of Surgery at Emory University where he also served as the Director of Clinical Research for the division of vascular surgery. Prior to joining NMTC Dr. Kasirajan was the Director of Clinical Research for the East Bay Cardiovascular and Thoracic Associates in Concord, California.
Manju Beier, Pharm.D, Chief Science Officer
Dr. Beier recently joined Natural Molecular as the Chief Science Officer. She received her Pharm D degree from the University of Utah and has been heavily involved in Geriatric Pharmacy and Pharmacogenomics research over the past 20+ years. She holds an academic position with the University of Michigan and is very well published in peer review journals.
Ken Webert, VP of Strategic Markets
Ken has spent the past 17 years as a sales professional, national trainer and national training manager with Amgen, Pfizer and Lilly. Prior to going into sales Ken spent over 6 years as a retail, hospital and long term care pharmacist. Ken’s passion is to develop the best sales force in the industry. Ken recently relocated back to Seattle from Los Angeles with his wife and twin boys.
Michael H. Kalnoski, M.D., Laboratory Medical Director
Dr. Kalnoski attended Saint Louis University School of Medicine, where he earned his M.D. He completed his residency at the University of Washington in Clinical and Anatomic pathology and a fellowship in Hematology and is triple board certified. He also received post-graduate training (MBA) at Saint Louis University and San Francisco State University; post-graduate training in cell and molecular biology at the University of California, Los Angeles (UCLA) and earned a B.A. in Chemistry from the University of Washington. Dr. Kalnoski has also served as a medical director at several regional hospitals and large reference laboratories (Quest Diagnostics) in Washington and Alaska.